# LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus

> **NCT05714930** · NA · RECRUITING · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 606 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **OTHER:** Treat-to-target as a new treatment concept

## Key facts

- **NCT ID:** NCT05714930
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-12
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 606 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05714930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05714930, "LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05714930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*